To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
New EIP: Support for bioeconomy key to productive and sustainable agriculture
05-03-2012: The Commission’s new European Innovation Partnership (EIP) sets the focus on the Common Agricultural Policy’s Rural Development Pillar and on the bioeconomy for delivering productive and sustainable agriculture across Europe.
“The world is set to change dramatically over the coming decades” commented Nathalie Moll, EuropaBio Secretary General, “with the impacts of climate change, a growing population and with 70% more food and 100% more energy needed by 2050 there will be increasing pressure on our natural resources. It’s vital that our future agriculture policy responds to these challenges by stimulating innovation and by producing more from less.”
Innovation in support of the bio-based economy has been identified as one of five central themes of the partnership, with special emphasis placed on supporting biorefineries and on strengthening the biobased value chain through improved information flow between farmers, researchers, scientists, NGOs and Industry.
This is well aligned with the Bioeconomy strategy published earlier this month. This strategy plots a roadmap for creating a society far less dependent on fossil fuels. Industrial Biotechnology plays a central role in achieving this, through the sustainable processing and production of products, chemicals, materials and fuels from biomass and agricultural waste, reducing the EU’s dependence on oil, coal and gas and creating jobs across a wide range of sectors and disciplines.
To grow a robust and dynamic bioeconomy, measures will be needed within the EIP to foster more effective use of the EU’s biomass resources. These include developing new facilities and infrastructures, such as demo biorefineries and logistical systems to collect and transport the biomass. This all needs to be implemented in an environmentally and economically sustainable way.
“Implemented well, this EIP could be great news for the building up of the biobased economy in Europe” stated Lars Hansen, Chair of EuropaBio’s Industrial Biotech Council. “We need to use all available tools to feed a growing population, to responsibly use the EU’s valuable natural resources and to re-centre agriculture as a driving force for the industrial economy. The biobased economy is part of the solution to address these multiple challenges.”
Contact / Request information
Request further information free of charge:
This is where you can add this news to your personal favourites
- 1Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 2Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 3Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 4Researchers divide enzyme to conquer genetic puzzle
- 5Merck & Co., Inc. Opens Asia Pacific Regional Headquarters in Singapore
- 6Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 7Sanofi-aventis to acquire Oenobiol
- 8Pharmexa enters into an agreement regarding GV1001 with the Korean company KAEL Co. Ltd
- 9DSM Sinochem Pharmaceuticals opens new 6-APA intermediate plant in China
- 10Pharmsynthez granted Orphan Drug Designation for Virexxa in the US
- PRAC recommends suspending marketing authorisations for infusion solutions c ...
- PRAC recommends restricting the use of flupirtine-containing medicines
- PRAC recommends restricting the use of codeine when used for pain relief in ...
- PRAC recommends the same cardiovascular precautions for diclofenac as for se ...
- Food Safety Criteria for listeria in smoked and gravad fish, and raw milk ch ...
- New angle to combat malignant brain tumors in children
- Ablynx and Spirogen enter in research collaboration for toxin-nanobody drug conjugates
- Bone Therapeutics Invests in Cell Therapy Manufacturing Facility
- Cell therapy a little more concrete thanks to VIB research
- Neupro approved in Japan for Parkinson’s disease and Restless Legs Syndrome